Fromme JE - Search Results

1

Sequencing of immunotherapy and targeted therapy for BRAF^V600 mutated melanoma: a retrospective study.

Persa OD, Fromme JE, Mauch C. Persa OD, et al. Among authors: fromme je. J Dtsch Dermatol Ges. 2021 Jun;19(6):902-904. doi: 10.1111/ddg.14329. Epub 2021 Feb 22. J Dtsch Dermatol Ges. 2021. PMID: 33617147 No abstract available.

2

Loss of ADAM9 Leads to Modifications of the Extracellular Matrix Modulating Tumor Growth.

Abety AN, Pach E, Giebeler N, Fromme JE, Aramadhaka LR, Mauch C, Fox JW, Zigrino P. Abety AN, et al. Among authors: fromme je. Biomolecules. 2020 Sep 7;10(9):1290. doi: 10.3390/biom10091290. Biomolecules. 2020. PMID: 32906814 Free PMC article.

3

Therapiesequenz von Immuntherapie und zielgerichteter Therapie beim BRAF^V600 -mutierten malignen Melanom: eine retrospektive Studie.

Persa OD, Fromme JE, Mauch C. Persa OD, et al. Among authors: fromme je. J Dtsch Dermatol Ges. 2021 Jun;19(6):902-905. doi: 10.1111/ddg.14329_g. J Dtsch Dermatol Ges. 2021. PMID: 34139097 German. No abstract available.

4

Melanoma metastasis, BRAF mutation and GJB5 connexin expression: a new prognostic factor.

Fromme JE, Zigrino P. Fromme JE, et al. Br J Dermatol. 2022 Jan;186(1):13-14. doi: 10.1111/bjd.20756. Epub 2021 Sep 30. Br J Dermatol. 2022. PMID: 34590708 No abstract available.

5

Extracellular Matrix Remodeling by Fibroblast-MMP14 Regulates Melanoma Growth.

Pach E, Kümper M, Fromme JE, Zamek J, Metzen F, Koch M, Mauch C, Zigrino P. Pach E, et al. Among authors: fromme je. Int J Mol Sci. 2021 Nov 12;22(22):12276. doi: 10.3390/ijms222212276. Int J Mol Sci. 2021. PMID: 34830157 Free PMC article.

6

Tenascin C is a valuable marker for melanoma progression independent of mutational status and MAPK inhibitor therapy.

Fromme JE, Dummer R, Mauch C, Zigrino P. Fromme JE, et al. Exp Dermatol. 2023 May;32(5):707-709. doi: 10.1111/exd.14717. Epub 2022 Dec 1. Exp Dermatol. 2023. PMID: 36437681 Free article. No abstract available.

7

The Role of Extracellular Matrix Remodeling in Skin Tumor Progression and Therapeutic Resistance.

Fromme JE, Zigrino P. Fromme JE, et al. Front Mol Biosci. 2022 Apr 26;9:864302. doi: 10.3389/fmolb.2022.864302. eCollection 2022. Front Mol Biosci. 2022. PMID: 35558554 Free PMC article. Review.

8

[Viral exanthems in children].

Fromme JE, Tantcheva-Poór I, Fölster-Holst R. Fromme JE, et al. Hautarzt. 2022 Jun;73(6):452-460. doi: 10.1007/s00105-022-05000-w. Epub 2022 May 25. Hautarzt. 2022. PMID: 35612655 Free PMC article. Review. German.

9

Gene-expression Profiling - A Decision Impact Analysis: Decision Dependency on Oncotype DX® as a Function of Oncological Work Experience in 117 Cases.

Eichler C, Fromme J, Thangarajah F, Puppe J, Paepke S, Warm M, Malter W. Eichler C, et al. Anticancer Res. 2019 Jan;39(1):297-303. doi: 10.21873/anticanres.13111. Anticancer Res. 2019. PMID: 30591472

10

The impact of EndoPredict ^® on decision making with increasing oncological work experience: can overtreatment be avoided?

Thangarajah F, Eichler C, Fromme J, Malter W, Caroline Radosa J, Ludwig S, Puppe J, Paepke S, Warm M. Thangarajah F, et al. Arch Gynecol Obstet. 2019 May;299(5):1437-1442. doi: 10.1007/s00404-019-05097-w. Epub 2019 Feb 19. Arch Gynecol Obstet. 2019. PMID: 30783737

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters